Navigation Links
Micromet to Present New Clinical Data on Blinatumomab at EHA and on Adecatumumab at ASCO
Date:5/20/2009

Activity of Blinatumomab in NHL and ALL Highlighted at the 14th Congress of the European Hematology Association (EHA)

Adecatumumab Combination Data in Breast Cancer to Be Presented at the American Society of Clinical Oncology (ASCO) Meeting

BETHESDA, Md., May 20 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced an oral(1) and a poster presentation(2) of blinatumomab data at the 14th Congress of European Hematology Association (EHA) taking place from June 4-7, 2009, in Berlin, Germany. Interim data from the phase 2 clinical trial with blinatumomab in patients with acute lymphoblastic leukemia (ALL) were chosen for an oral presentation, while an update from the phase 1 trial with blinatumomab in patients with non-Hodgkin's lymphoma (NHL) will be presented in a poster and include additional data on the durability of responses last presented at the American Society of Hematology meeting in December 2008 and efficacy data from additional patients.

Micromet also announced a poster presentation(3) for adecatumumab at the 45th annual meeting of ASCO taking place from May 29 - June 2 in Orlando, Florida. The new data will include an update of the data presented at the European Society of Oncology (ESMO) meeting in October of 2008.

(1) Topp et al, (2009) Blinatumomab (anti-CD19 BiTE(R)) for targeted therapy of minimal residual disease (MRD) in patients with B precursor acute lymphoblastic leukemia (ALL): Update of an ongoing phase II study. 14th Congress of EHA (2009), abstract number 482; oral presentation on June 6 in Hall 15.2 at 8:15 AM.

(2) Klinger, et al. (2009) Pharmacodynamic analyses of peripheral blood from relapsed B-NHL pat
'/>"/>

SOURCE Micromet, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Micromet, Inc. to Present at the Sal. Oppenheim 2nd European Healthcare Conference
2. Micromet to Present at the Sachs Associates 7th Annual Biotech in Europe Investor Forum
3. Micromet Data Presented at the International AACR-NCI-EORTC Conference Support the Development of Adecatumumab (MT201) in Earlier Stage Cancer Disease Settings
4. Micromet is Presenting Four Posters on BiTE(R) Antibodies at the International AACR-NCI-EORTC Conference
5. Micromet to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference on November 7, 2007
6. Micromet, Inc. Elects Joseph P. Slattery to Board of Directors
7. Micromet to Present at the 2007 RBC Capital Markets Healthcare Conference on December 12, 2007
8. Micromet to Present at Two Upcoming Investor Conferences
9. Micromet to Present at the Susquehanna Financial Groups SIGnificant Investment Options Conference on March 4, 2008
10. Micromet, Inc. to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2007 Financial Results
11. Micromet, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... About Bioactive Material Bioactive ... are increasingly becoming popular due to their ability ... having a negative impact on the human health. ... tissue repair materials in surgical procedures. Bioactive materials ... glass-ceramics, and composites. The major end-users of bioactive ...
(Date:9/23/2014)... France (PRWEB) September 23, 2014 ... of laboratory personnel since 1968 and Burdinola, supplier of ... of a new filtered fume hood. , ... laboratory fume hood, Burdinola will now offer an innovative ... a wide range of chemicals, best-in-class detection technology, and ...
(Date:9/23/2014)... ATCC, the premier global biological materials resource and ... to the senior leadership team. Barbie Bigelow has joined ... and Dr. Maryellen de Mars also joins as the ... are new positions at ATCC. , ... described the additions as part of a revitalization strategy ...
(Date:9/23/2014)... September 23, 2014 Follow ... gaining steady popularity the world over, due to ... Growth in the marketplace is expected to come ... in developing countries. Several sub-Saharan countries in the ... have already implemented genetically engineered crop production strategies. ...
Breaking Biology Technology:Global Bioactive Material Market 2014-2018 2Erlab Partners with Burdinola to Deliver an Innovative Filtered Fume Hood 2ATCC Announces New Appointments to its Leadership Team 2ATCC Announces New Appointments to its Leadership Team 3Rising Focus on Food Security Spurs Growth in the Global Agricultural Biotechnology Market, According to New Report by Global Industry Analysts, Inc. 2Rising Focus on Food Security Spurs Growth in the Global Agricultural Biotechnology Market, According to New Report by Global Industry Analysts, Inc. 3Rising Focus on Food Security Spurs Growth in the Global Agricultural Biotechnology Market, According to New Report by Global Industry Analysts, Inc. 4
... chemical reaction that causes iron to rust plays a similarly ... healthy cells and is a process, scientists know, that contributes ... from Alzheimer,s, heart disease and stroke to cancer and the ... edition (Feb. 21, 2008) of the journal Nature, a team ...
... ... Accuracy, PITTSBURGH, Feb. 20 Applied Isotope Technologies,("AIT") ... edition of the Federal Register as a part of the methods,section of ... Recovery Act). This updated version of the method includes,a long list of ...
... TAMPA, Fla., Feb. 20 Sirion Therapeutics, ... that it has entered into an exclusive ... FL for the worldwide rights to develop ... anti- inflammatory agent norketotifen., (Logo: ...
Cached Biology Technology:Genetic pathway critical to disease, aging found 2Genetic pathway critical to disease, aging found 3Newly Published EPA RCRA Method 6800 Supports AIT Technology 2Sirion Therapeutics Acquires Worldwide License to Develop New Treatment for Ocular Diseases 2
(Date:9/23/2014)... have encountered variants or isoforms in microRNAs (miRNAs) before, ... recent study, published in the journal Oncotarget ... abundances that depend on geographic subpopulations and gender and ... may not be the one typically listed in the ... are much more common than we had previously assumed. ...
(Date:9/23/2014)... When the body forms new tissues during ... communicate with each other. For years, scientists believed ... researchers at Carnegie Mellon University and the University ... mechanical communication is equally if not more ... of the Proceedings of the National Academy ...
(Date:9/23/2014)... are fighting a cyberwar against cancer finds that the ... , "Recent research has found that cancer is already ... we studied the interplay between cancer and the immune ... on cancer," said Rice University,s Eshel Ben-Jacob, co-author of ... of the Proceedings of the National Academy of ...
Breaking Biology News(10 mins):Slight alterations in microRNA sequences hold more information than previously thought 2Slight alterations in microRNA sequences hold more information than previously thought 3The mechanics of tissue growth 2Immune system is key ally in cyberwar against cancer 2Immune system is key ally in cyberwar against cancer 3
... microscopic organ-on-a-chip devices that mimic the way real organs ... effects of therapies more accurately, will be discussed by ... week. Professor Don Ingber, Director of the ... will deliver the inaugural Bagrit Lecture, which will be ...
... Nitrogen pollution in our coastal ecosystems, the result of ... sewage, leads to decreased water transparency, the loss of ... speciessuch as the algae behind the renowned "red tides" ... pronounced in the Gulf of Mexico and the Caribbean. ...
... could a colorblind animal know how to change its ... will the animal,s predator "see," looking at its prey ... are addressed in article published today by a collaborative ... Hole, Mass., and the U.S. Military Academy in West ...
Cached Biology News:Media invitation: Pioneer of organ-on-a-chip technology to speak at Imperial College London 2Sewage-derived nitrogen increasingly polluting Caribbean ecosystems 2How can a colorblind animal change its colors to blend into the background? 2How can a colorblind animal change its colors to blend into the background? 3
... a partial recombinant IFNA2. Immunogen: ... is produced in E. coli. The biological ... OMIM: 147562, ... MM951100564 MA Code: ABV0P9DPB ...
Mouse monoclonal antibody raised against a partial recombinant STAU2. NCBI Entrez Gene ID = STAU2...
Mouse polyclonal antibody to NR2F2 - nuclear receptor subfamily 2, group F, member 2...
Mouse monoclonal antibody raised against a full length recombinant YARS. NCBI Entrez Gene ID = YARS...
Biology Products: